{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137045608920320.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2146/ajhp040555"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/ajhp/article-pdf/62/15/1596/28323475/ajhp1596.pdf"}}],"dc:title":[{"@value":"Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137045608920320","@type":"Researcher","foaf:name":[{"@value":"C. A. (CAB) Bond"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045608920321","@type":"Researcher","foaf:name":[{"@value":"Cynthia L. Raehl"}],"jpcoar:affiliationName":[{"@value":"Chair of Clinical Research and Development, Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center—Amarillo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10792082"},{"@type":"EISSN","@value":"15352900"}],"prism:publicationName":[{"@value":"American Journal of Health-System Pharmacy"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2005-08-01","prism:volume":"62","prism:number":"15","prism:startingPage":"1596","prism:endingPage":"1605"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/ajhp/article-pdf/62/15/1596/28323475/ajhp1596.pdf"}],"createdAt":"2005-10-28","modifiedAt":"2024-01-31","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390571503514017280","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN"},{"@language":"ja","@value":"抗菌薬適正使用支援プログラム実践のためのガイダンス"},{"@value":"委員会報告 抗菌薬適正使用支援プログラム実践のためのガイダンス"},{"@language":"ja-Kana","@value":"イインカイ ホウコク コウキンヤク テキセイ シヨウ シエン プログラム ジッセン ノ タメ ノ ガイダンス"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2146/ajhp040555"},{"@type":"CROSSREF","@value":"10.11150/kansenshogakuzasshi.91.709_references_DOI_WH54g4kiJZPBGXqDA2NcLtrq2sp"}]}